Prognostic factors in the acute respiratory distress syndrome;Factores pronosticos en el sindrome de distres respiratorio agudo

Medicina Intensiva

Volumn 23, Issue 8, 1999, Pages 354-360

  Burgueno Campinez M J ^a   Masclans Enviz, J R ^a   Angles Coll R ^a   Ferrer Roca, R ^a   De Latorre Arteche, F J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute respiratory distress syndrome; Acute respiratory failure; Complications; Mortality; Prognostic factors

Indexed keywords

INOTROPIC AGENT; NITRIC OXIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CAUSE OF DEATH; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OXYGENATION; PROGNOSIS; RESPIRATORY DISTRESS; SEPSIS; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0032724916     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 233-239.
2. Petty TL, Ashbaugh DG. The adult respiratory distress syndrome: clinical features, factors influencing prognosis and principles of management. Chest 1971; 60: 233-239.
3. de Latorre FJ, Tomasa A, Leon C, Peracaula R, Figueras J, Soler M, et al. Síndrome de distress respiratorio del adulto (pulmón de shock). Med Clín 1974; 62: 162-167.
4. Seekamp A, Obertacke U, Sturm JA. Extravascular lung water clinical methodology. En Sturm JA, ed. Adult respiratory distress syndrome. Berlin: Springer-Verlag, 1991; 11-16.
5. Harris TR, Bernard GR, Brigham KL, Higgins SB, Rinaldo JE, Borovetz HS, et al. Lung microvascular transport properties measured by multiple indicator dilution methods in patients with adult respiratory distress syndrome Am Rev Respir Dis 1990; 141: 272-280.
6. Bernard GP, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al The american-european consensus conference on ARDS definitions, mechanisms, relevant outcomes, and clinical trial coordination Am J Respir Crit Care Med 1994; 149: 818-824.
7. National Heart and Lung Institute. Respiratory diseases. Task force report on problems, research, approaches, needs. Washington DC: US Government Printing Office, 1972, 167-180 (DHEW Publication n.o (NIH) 73-472. 15. N R.
8. Webster NR, Cohen AT, Nunn JF. Adult respiratory distress syndrome -how many casein the UK? Anaesthesia 1988; 43: 923-926.
9. Lewandowski K, Metz J, Deutschmann C, Preib H, Kuhlen R, Artigas A, Falke KJ. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med 1995; 151: 1.121-1.125.
10. Villar J, Slutsky AS. The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140: 814-816.
11. Krafft P, Fridrich P, Pernerstorfer T, Fitzgerald RD, Koc D, Schneider B, et al. The acute respiratory distress syndrome: definitions, severity and clinical outcome. Intensive Care Med 1996; 22: 519-529.
12. Dellinger RP. Clinical trials in adult respiratory distress syndrome. New Horizons 1993; 1: 584-592.
13. Swank DW, Breanndan S. Roles of the neutrophil and other mediators in ARDS. Mayo Clin Proc 1989; 64: 1.118-1.132.
14. Rinaldo JR. Mediation of ARDS by leukocytes Chest 1986; 89: 590-593.
15. Meduri GU. The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment Eur Respir J 1996; 9: 2.650-2.670.
16. de la Cruz CA, Fernández-Quero L, Estecha MA, Nieto M, Romera MA, Chamorro C. Papel fisiopatológico de los mediadores de la respuesta inflamatoria en el SDRA. Anales de Cuidados Intensivos 1994; 7: 214-225.
17. Cunningham AJ. Acute respiratory distress syndrome: two decades later. Yale J Biol Med 1991; 64: 387-402.
18. Snow RL, Davies P, Pontoppidan H, Zapol WM, Reid L. Pulmonary vascular remodeling in adult respiratory distress syndrome Am Rev Respir Dis 1982; 126: 887-892.
19. Masclans JR, Bermejo B, Picó M, de Latorre FJ, Rodríguez-Roism R, Planas M. Valor pronóstico de los eicosanoides en el síndrome de distrés respiratorio agudo. Med Clín (Barc) 1999 (en prensa)
20. Kollef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med 1995; 332: 27-37
21. Planas M, Masclans JR, Iglesia R, Porta I, Valls M, Bermejo B. Eicosanoids and fat emulsions in acute respiratory distress syndrome. Nutrition 1997; 13: 202-205.
22. Hudson LD. New therapies for ARDS. Chest 1995; 108: 79s-91s.
23. Villar J, Villalobos J, Quintana J, Manzano JL No existen diferencias hemodinámicas en pacientes con SDRA, con sepsis o sin ella. Med Clín (Barc) 1992; 98: 281-284.
24. Steltzer H, Krafft P. Prognosis of ARDS patients: light at the end of the tunnel. Intensive Care Med 1997; 23: 803-805.
25. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM Inhaled nitric oxide for the ARDS. N Engl J Md 1993; 328: 399-405.
26. Anglès R, Masclans JR. Utilización clínica del óxido nítrico inhalado. Farmacéutico Hospitales 1998; 80: 14-19.
27. Dean J Turning to the past. Lancet 1997; 350 (SIII): 3.
28. Masclans JR, Anglès R. Influencia de la posición en pacientes con insuficiencia respiratoria aguda. Farmacéutico Hospitales 1998 (en prensa).
29. Murray JF, Matthay MA, Luce JM, Flick M. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-723.
30. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) socre to describe organ dysfunction/failure. Intensive Care Med 1996; 22 707-710.
31. Ferrer R, Masclans JR, Anglès R, Picó M, Millan B, Planas M, de Latorre FJ. Anticoagulative effect of nitric oxide inhalation in ARDS Intensive Care Med 1998; 24: 837-838.
32. Beloucif S, Payen D, and the working group on inhaled NO in the ICU of the European Society of Intensive Care Medicine A European survey of the use of inhaled nitric oxide in the ICU. Intensive Care Med 1998; 24: 864-877.
33. Masclans JR, Ferrer R, Picó M, Anglès R, Claraco MC, Planas M, de Latorre FJ Bleeding risk after 48 h of nitric oxide inhalation in ARDS. Intensive Care Med 1998; 24: S33.
34. Masclans JR, Burgueño MJ, Bermejo B, Anglès, R, Ferrer R, de Latorre FJ. Síndrome de distrés respiratorio agudo: incidencia y evolución en una UCI española. Rev Clín Esp 1998; 198: 278-283.
35. Garber BG, Hébert PC, Yelle JD, Hodder RV, McGowan J. Adult respiratory distress syndrome: a systematic overview of incidence and risk factors. Crit Care Med 1996; 24: 287-295
36. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Mathay MA. Identification of patients with acute lung injury: predictors of mortality. Am J Respir Crit Care Med 1995; 152: 1.818-1824.
37. Masclans JR, Iglesia R, Bermejo B, Pico M, Rodríguez-Roisin R, Planas M. Gas exchange and pulmonary haemodynamic responses to fat emulsions in ARDS. Intensive Care Med 1998; 24: 918-923.
38. Nolan S, Gurgess K, Hopper L, Braude S. Acute respiratory distress syndrome in a community hospital ICU. Intensive Care Med 1997; 23: 530-538.
39. Lewandowski K, Rossaint R, Pappert D, Gerlach H, Slama KJ, Weidemann H, et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 1997; 23: 819-835.
40. Higgembotham T, Pepke-Zaba J, Scott J, Woolman P, Coutts C, Wallwork J. Inhaled "endothelium derived-relaxing factor" (EDRF) in primary hypertension (PPH). Am Rev Respir Dis 1988; 173: 107.
41. Borelli M, Denkewitz T, Elia S, Lampati L, Vascotto E, Pesenti A. Inhaled NO in the treatment of ARDS patients. Clinical experience. Intensive Care Med 1997; 23: S1.
42. Lundin S, Mang H, Smithies S, Stenqvist O, Frostell C, for the European Study Group of Inhaled NO. Inhalation of NO in acute lung injury: preliminary results of a european multicenter study Intensive Care Med 1997; 23: S2.
43. Troncy E, Collet JP, Shapiro S, Guimond JG, Blair L, Charbonneau M, Blaise G. Should we treat acute respiratory distress syndrome with inhaled nitric oxyde? Lancet 1997; 350: 111-112.
44. Montgomery AB, Stager MA, Carrico CJ, Hudson LD Causes of mortality in patients with the adult respiratory distress syndrome Am Rev Respir Dis 1985; 132: 485-489.
45. Conejero R, Matín MT, García J, Masa JF, Alvarez A, de la Torre R, et al. Síndrome de distrés respiratorio del adulto: experiencia de 4 años Med Clín (Barc) 1986; 87: 830-838.
46. Heffner JE, Brown LK, Barbieri CA, Harpel KS, Deleo J Prospective validation of an acute respiratory distress syndrome predictive score. Am J Respir Crit Care Med 1995; 152: 1.518-1.526.
47. Artigas A, Carlet J, Le Gall JR, Castang CL, Blanch L, Fernández R. Clinical presentation, prognostic factors, and outcome of ARDS in the European Colloborative Study (1985-1987). En: Zapol WM, Lemaire F, eds. Adult respiratory distress syndrome. New York: Marcel Dekker, Inc., 1991; 50: 37-63.
48. Fowler AA, Hamman RF, Zerbe GO, Benson KN, Hyers TM. Adult respiratory distress syndrome: prognosis after onset. Am Rev Respir Dis 1985, 132: 472-478.
49. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273: 306-309.
50. Yukioka H, Nakatani K Acute Respiratory Distress Syndrome in a University hospital ICU in Japan. Crit Care 1999; 3 (S1): 33.
51. Luhr O, Aardal S, Nathorst - Westfelt U, Berggren L, Johansson LA, Wahlin L, Frostell C. Pulmonary function in adult survivors of severe acute lung injury treated with inhaled nitric oxyde. Acta Anaesthesiol Scand 1998; 42 391-398.
52. Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP Reduced quality of life in survivors of ARDS compared with critically ill control patients. JAMA 1999; 281: 354-360.